These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9667670)

  • 1. Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study.
    Guerry M; Vabre L; Talbot M; Mamelle G; Leridant AM; Hill C; Bosq J; Luboinski B; Janot F
    Br J Cancer; 1998 Jun; 77(11):1932-6. PubMed ID: 9667670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin alterations as diagnostic and prognostic markers of oral and pharyngeal carcinomas. A prospective study.
    Depondt J; Shabana AH; Sawaf H; Gehanno P; Forest N
    Eur J Oral Sci; 1999 Dec; 107(6):442-54. PubMed ID: 10625103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers of radioresistance in squamous cell carcinomas of the head and neck: a clinicopathologic and immunohistochemical study.
    Raybaud-Diogène H; Fortin A; Morency R; Roy J; Monteil RA; Têtu B
    J Clin Oncol; 1997 Mar; 15(3):1030-8. PubMed ID: 9060543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of p53, c-erb-B2 and MIB-1 in endometrial carcinoma.
    Cherchi PL; Marras V; Capobianco G; Ambrosini G; Piga MD; Fadda GM; Rosas N; Dessole S
    Eur J Gynaecol Oncol; 2001; 22(6):451-3. PubMed ID: 11874080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A; Koukourakis MI; Sivridis E; Fountzilas G
    Anticancer Res; 2000; 20(2A):997-1004. PubMed ID: 10810387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mucoepidermoid carcinoma of salivary glands: the prognostic value of tumoral markers].
    Hoyek-Gebeily J; Nehmé E; Aftimos G; Sader-Ghorra C; Sargi Z; Haddad A
    Rev Stomatol Chir Maxillofac; 2007 Dec; 108(6):482-8. PubMed ID: 17761202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
    Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
    Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermoid carcinoma of the lip: an immunohistochemical study.
    García-Montesinos-Perea B; Val-Bernal JF; Saiz-Bustillo R
    Med Oral Patol Oral Cir Bucal; 2005; 10(5):454-61. PubMed ID: 16264381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma.
    Moldvay J; Scheid P; Wild P; Nabil K; Siat J; Borrelly J; Marie B; Farré G; Labib T; Pottier G; Sesboüé R; Bronner C; Vignaud JM; Martinet Y; Martinet N
    Clin Cancer Res; 2000 Mar; 6(3):1125-34. PubMed ID: 10741743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time.
    Heinze T; Jonas S; Kärsten A; Neuhaus P
    Anticancer Res; 1999; 19(4A):2501-3. PubMed ID: 10470182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination.
    Franchi A; Gallo O; Boddi V; Santucci M
    Clin Cancer Res; 1996 Oct; 2(10):1801-8. PubMed ID: 9816133
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [C-erbB-2, EGF receptor, p53 and PCNA. The prognostic significance of recent tumor markers for lymph node negative breast cancer].
    Schönborn I; Minguillon C; Lichtenegger W; Zschiesche W; Spitzer E
    Geburtshilfe Frauenheilkd; 1995 Oct; 55(10):566-71. PubMed ID: 8543129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical study of p53, EGF, EGF-receptor, v-erb B and ras p21 in squamous cell carcinoma of hypopharynx.
    Otsu M; Hayashi Y; Amatsu M; Itoh H
    Kobe J Med Sci; 1994 Dec; 40(5-6):139-53. PubMed ID: 7616733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M
    J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunohistochemical tumor markers in infiltrating ductal breast carcinoma].
    Gallegos M; González S; León A; Claure R; Goñi I; Andrade L; Duarte I
    Rev Med Chil; 1998 Oct; 126(10):1216-23. PubMed ID: 10030093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of histological and biological markers in pharyngeal squamous cell carcinoma: a case-control study.
    Carinci F; Carls PF
    Br J Cancer; 2000 May; 82(9):1613-4. PubMed ID: 10789735
    [No Abstract]   [Full Text] [Related]  

  • 17. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncoprotein (c-myc, c-erbB1, c-erbB2, c-fos) and suppressor gene product (p53) expression in squamous cell carcinomas of the lung. Clinical and biological correlations.
    Volm M; Efferth T; Mattern J
    Anticancer Res; 1992; 12(1):11-20. PubMed ID: 1348920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic endocrine tumors-c-erb B2 (Her-2/neu), bcl-2, and p-53 immunohistochemical testing and their value in assessing prognosis.
    Proca DM; Frankel WL
    Appl Immunohistochem Mol Morphol; 2008 Jan; 16(1):44-7. PubMed ID: 18091321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between ploidy status, Erb-B2 and p53 immunohistochemical expression in primary breast carcinoma.
    Midulla C; Giovagnoli MR; Valli C; Vecchione A
    Anal Quant Cytol Histol; 1995 Jun; 17(3):157-62. PubMed ID: 7546049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.